NUZ 8.11% 20.0¢ neurizon therapeutics limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-164

  1. 8,973 Posts.
    lightbulb Created with Sketch. 1758
    Well we are charging towards the end of February with 11 days now left in the month so not long now to see the data and outcome of the final report.
    Data that will be handed to the FDA to support the ODD application
    Should also find out about the market survey around canine cancer
    Our CEO and researchers very confident of a great outcome from the phase 1 trial data
    12 patient still alive which is highly unlikely after this amount of time, all the 12 patients still having the ability to at least swallow and all electing to stay on mpl.
    Even I am starting to get a bit excited
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.015(8.11%)
Mkt cap ! $98.34M
Open High Low Value Volume
19.0¢ 20.0¢ 19.0¢ $66.44K 346.2K

Buyers (Bids)

No. Vol. Price($)
3 86359 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 107894 5
View Market Depth
Last trade - 15.42pm 13/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.